Page 19 - Synapse Life Sciences Consortium
P. 19

VoxNeuro:

                                                                     “Hamilton is a
                                                                     Beachhead for US
                                                                     Expansion”


                                                                     VoxNeuro is a neuroscience and health
                                                                     tech company, co-founded by McMaster
                                                                     linguistics professor Dr. John Connolly,
                                                                     that has developed technologies to
                                                                     objectively measure real-time cognitive
                                                                     functions to support care for those with
                                                                     dementia and cognitive dysfunctions,
                                                                     concussions, and other brain disorders.

                                                                     Working with MILO, The Forge,
                                                                     Innovation Factory, and Bay Area Health
                                                                     Trust, the VoxNeuro team was able to
                                                                     successfully secure intellectual property,
                                                                     develop relevant connections with
                                                                     champions in the healthcare industry,
                                                                     and land funding. Its software platform
                                                                     recently secured Health Canada and
                                                                     FDA approvals and the company is
                                                                     assembling plans to roll out to clinics
                                                                     across North America.


                                                                     In 2020, VoxNeuro was selected by a
                                                                     panel of venture capitalists and digital
          “miP gives our researchers a natural pathway               health leaders as one of 11 companies
          to commercialize their work and the necessary              to participate in the Canadian
          infrastructure to spin out their research to create        Technology Accelerators Digital Health
          start-up companies. i really believe miP is a game-        Program that connected VoxNeuro with
          changer in our ability to attract and retain industry      resources to help facilitate its U.S.
          and all of the talent that’s affiliated with that.”
                                                                     expansion.
          “now is the time to take root in Hamilton, invest in       “The city and its life sciences
          Hamilton, and be part of its next chapter,” says ty        community has fostered a culture of
          Shattuck, CEo at miP .                                     innovation and collaboration, and it
                                                                     has a palpable ‘build-it’ mentality that
          “Hamilton is transforming from a city renowned for         is inspirational to be a part of,” said
          its deep research capabilities to one that is a rich       James Connolly, CEO.
          talent-centric generator that is creating jobs and
          innovative ventures out of that research. our goal         Hamilton’s location, close to both
          is to maximize the full potential of our ecosystem         Toronto and Kitchener-Waterloo in
          so that we can leverage the true benefits of life          Ontario and to New York state is a
          sciences and biotechnology; moving start-ups to
          scale-ups and launching biomanufacturing.”                 strategic advantage for VoxNeuro.
                                                                     “Hamilton not only serves as our
          “this is what makes miP and the city of Hamilton so        headquarters but also acts as a
          unique. our strategic location, existing life sciences     beachhead for our expansion into the
          cluster, and our commitment to work together will          U.S. market.”
          drive our growth in biomanufacturing”, commented
          Shattuck.

                                       [Continued on next page]                                 19
   14   15   16   17   18   19   20   21   22   23   24